Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease.
Orfanoudaki E, Zacharopoulou E, Kitsou V, Karmiris K, Theodoropoulou A, Mantzaris GJ, Tzouvala M, Michopoulos S, Zampeli E, Michalopoulos G, Karatzas P, Viazis N, Liatsos C, Bamias G, Koutroubakis IE, On Behalf Of The Hellenic Group For The Study Of Ibd. Orfanoudaki E, et al. Among authors: kitsou v. J Clin Med. 2022 Jan 27;11(3):641. doi: 10.3390/jcm11030641. J Clin Med. 2022. PMID: 35160092 Free PMC article.
Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry.
Zacharopoulou E, Orfanoudaki E, Tzouvala M, Tribonias G, Kokkotis G, Kitsou V, Almpani F, Christidou A, Viazis N, Mantzaris GJ, Tsafaridou M, Karmiris K, Theodoropoulou A, Papathanasiou E, Zampeli E, Michopoulos S, Tigkas S, Michalopoulos G, Laoudi E, Karatzas P, Mylonas I, Kyriakos N, Liatsos C, Kafetzi T, Theocharis G, Taka S, Panagiotopoulou K, Koutroubakis IE, Bamias G. Zacharopoulou E, et al. Among authors: kitsou v. Inflamm Bowel Dis. 2023 Feb 1;29(2):228-237. doi: 10.1093/ibd/izac068. Inflamm Bowel Dis. 2023. PMID: 35394529 Free PMC article.
Prevalence and predictors of arthralgia after initiation of vedolizumab in patients with inflammatory bowel disease: a retrospective cohort study.
Kokkotis G, Zampeli E, Tzouvala M, Giotis I, Orfanos P, Benetou V, Stoupaki M, Leontidis N, Leonidakis G, Kitsou V, Gaki A, Lagiou P, Michopoulos S, Bamias G. Kokkotis G, et al. Among authors: kitsou v. Eur J Gastroenterol Hepatol. 2023 Apr 1;35(4):371-375. doi: 10.1097/MEG.0000000000002527. Epub 2023 Feb 13. Eur J Gastroenterol Hepatol. 2023. PMID: 36827531
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study.
Allocca M, Catalano G, Savarino EV, Chaparro M, Levartovsky A, Michalopoulos G, Viazis N, Fousekis FS, Psistakis A, Noviello D, Nascimento CND, Caron B, Kitsou V, Bamias G, García MJ, Zacharopoulou E, Foteinogiannopoulou K, D'Amico F, Koutroubakis I, Ellul P, Tzouvala M, Peyrin-Biroulet L, Torres J, Caprioli F, Karmiris K, Theodoropoulou A, Katsanos KH, Christodoulou DK, Mantzaris GJ, Kopylov U, Gisbert JP, Danese S, Magro F, Carla F, Fiorino G. Allocca M, et al. Among authors: kitsou v. United European Gastroenterol J. 2024 Feb 28. doi: 10.1002/ueg2.12492. Online ahead of print. United European Gastroenterol J. 2024. PMID: 38419274 Free article.
Chronic renal failure and periodontal disease.
Kitsou VK, Konstantinidis A, Siamopoulos KC. Kitsou VK, et al. Ren Fail. 2000 May;22(3):307-18. doi: 10.1081/jdi-100100874. Ren Fail. 2000. PMID: 10843241 Clinical Trial.
14 results